Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Filings indexed 501 across all filing types
Latest filing 2017-11-21 Regulatory Filings
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Reporting of transactions made by persons discharging managerial responsibilities in Orphazyme A/S
Regulatory Filings
2017-11-21 English
Share Issue/Capital Change 2017
Share Issue/Capital Change Classification · 99% confidence The document is titled "Orphazyme A/S: Completion of the Offering and registration of share capital increase" and explicitly announces the completion of an Initial Public Offering (IPO) and the subsequent registration of a share capital increase with the Danish Business Authority. This directly relates to fundraising, financing activities, and changes in the capital structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a general earnings release (ER), a full annual report (10-K), or just a notice of dividend (DIV).
2017-11-20 English
Orphazyme A/S: Completion of the Offering and registration of share capital increase
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement regarding the completion of an Initial Public Offering (IPO) and the subsequent registration of a share capital increase. It details the listing on Nasdaq Copenhagen, the issuance of new shares, and the transition of trading symbols. This falls under the category of share issuance and capital structure changes.
2017-11-20 English
Share Issue/Capital Change 2017
Share Issue/Capital Change Classification · 99% confidence The document is a formal company announcement from Orphazyme A/S dated November 20, 2017, regarding the status of its Initial Public Offering (IPO). Specifically, it confirms that the IPO will *not* be terminated or withdrawn and that admission to trading on Nasdaq Copenhagen will proceed. This announcement relates directly to the process of raising capital and listing shares, which falls under financing activities. While it is an announcement, it is not a general regulatory filing (RNS) or a report publication announcement (RPA) in the sense of announcing a financial report. It is a specific update on a capital market event. The most fitting category among the provided definitions is 'Capital/Financing Update' (CAP), as it confirms the successful progression of the IPO process.
2017-11-20 English
Orphazyme A/S: No termination or withdrawal of Orphazyme's IPO
Capital/Financing Update Classification · 95% confidence The document is a company announcement from Orphazyme regarding the status of its Initial Public Offering (IPO). It confirms that the underwriting agreement remains in place and the IPO will not be terminated or withdrawn. This relates to capital raising and financing activities. While it mentions the IPO, it is an announcement regarding the status of the offering process rather than a full prospectus or a report publication announcement. Given the focus on the IPO process and underwriting status, it falls under Capital/Financing Update.
2017-11-20 English
Orphazyme A/S: No termination or withdrawal of Orphazyme's IPO
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the status of an Initial Public Offering (IPO), specifically confirming that the underwriting agreement has not been terminated and the IPO will proceed. This relates to capital raising and financing activities. While it mentions the IPO, it is an announcement of the status of the offering rather than a prospectus or a financial report. Given the nature of the announcement regarding capital structure and financing, 'CAP' (Capital/Financing Update) is the most appropriate classification.
2017-11-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.